Zika getting on your nerves? the association with the Guillain-Barré syndrome

New England Journal of Medicine

Volumn 375, Issue 16, 2016, Pages 1581-1582

  Frontera, Jennifer A ^a   Da Silva, Ivan R F ^b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Neurocritical Care Department   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY;

CELL CULTURE; CEREBROSPINAL FLUID ANALYSIS; CHIKUNGUNYA VIRUS; CROSS REACTION; DENGUE VIRUS; DISEASE ASSOCIATION; EDITORIAL; ENDEMIC DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; INCIDENCE; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SERUM; SYMPTOM; URINALYSIS; VIRUS NEUTRALIZATION; WEST NILE VIRUS; YELLOW FEVER VIRUS; ZIKA FEVER; ZIKA VIRUS;

GUILLAIN-BARRE SYNDROME; HUMANS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84992088259     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1611840     Document Type: Editorial

References (11)

1. Parra B, Lizarazo J, Jiménez-Arango JA, et al. Guillain-Barré syndrome associated with Zika virus infection in Colombia. N Engl J Med 2016; 375:1513-23.
2. Mansfield KL, Horton DL, Johnson N, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol 2011; 92: 2821-9.
3. Update on interim Zika virus clinical guidance and recommendations: Clinician Outreach and Communication Activity (COCA) call. Atlanta: Centers for Disease Control and Prevention, February 25, 2016 (http://emergency .cdc .gov/coca/ppt/2016/03-3-16-zika-update .pdf).
4. Laboratory testing for Zika virus infection. Geneva: World Health Organization, March 23, 2016 (http://apps .who .int/iris/bitstream/10665/204671/1/WHO-ZIKV-LAB-16 .1-eng .pdf?ua=1).
5. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47: 303-27.
6. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011; 29: 599-612.
7. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.
8. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016; 387: 1531-9.
9. da Silva IR, Frontera JA, Moreira do Nascimento OJ. News from the battlefront: Zika virus-associated Guillain-Barré syndrome in Brazil. Neurology 2016 July 15 (Epub ahead of print).
10. Tang H, Hammack C, Ogden SC, et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 2016; 18: 587-90.
11. Lucchese G, Kanduc D. Zika virus and autoimmunity: from microcephaly to Guillain-Barré syndrome, and beyond. Autoimmun Rev 2016; 15: 801-8.